Tehran University of Medical Sciences

Science Communicator Platform

Share By
Nano-Structures Mediated Co-Delivery of Therapeutic Agents for Glioblastoma Treatment: A Review Publisher Pubmed



Mujokoro B1 ; Adabi M2 ; Sadroddiny E3 ; Adabi M2 ; Khosravani M4
Authors

Source: Materials Science and Engineering C Published:2016


Abstract

Glioblastoma is a malignant brain tumor and leads to death in most patients. Chemotherapy is a common method for brain cancer in clinics. However, the recent advancements in the chemotherapy of brain tumors have not been efficient enough. With the advancement of nanotechnology, the used drugs can enhance chemotherapy efficiency and increase the access to brain cancers. Combination of therapeutic agents has been recently attracted great attention for glioblastoma chemotherapy. One of the early benefits of combination therapies is the high potential to provide synergistic effects and decrease adverse side effects associated with high doses of single anticancer drugs. Therefore, brain tumor treatments with combination drugs can be considered as a crucial approach for avoiding tumor growth. This review investigates current progress in nano-mediated co-delivery of therapeutic agents with focus on glioblastoma chemotherapy prognosis. © 2016 Elsevier B.V.
Related Docs
View other Related Docs
1. The Therapeutic Effect of Mrna Vaccines in Glioma: A Comprehensive Review, Expert Review of Clinical Immunology (2025)
2. Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms, Vaccines (2022)
3. Quercetin and Glioma: Which Signaling Pathways Are Involved?, Current Molecular Pharmacology (2022)
Experts (# of related papers)
View all Related Experts
Nima Rezaei (2)
Amir Ali Hamidieh (1)
Other Related Docs
4. Novel Management of Glioma by Molecular Therapies, a Review Article, European Journal of Translational Myology (2019)
5. Enhanced Bbb and Bbtb Penetration and Improved Anti-Glioma Behavior of Bortezomib Through Dual-Targeting Nanostructured Lipid Carriers, Journal of Controlled Release (2022)
6. The Effects of Chitosan-Based Materials on Glioma: Recent Advances in Its Applications for Diagnosis and Treatment, International Journal of Biological Macromolecules (2021)
7. Intra-Lesion Injection of Activated Natural Killer (Nk) Cells in Recurrent Malignant Brain Tumors, International Immunopharmacology (2023)
8. Comparison of Three Synthetic Transferrin Mimetic Small Peptides to Promote the Blood–Brain Barrier Penetration of Vincristine Liposomes for Improved Glioma Targeted Therapy, International Journal of Pharmaceutics (2022)
9. Clinical Effects of Immuno-Oncology Therapy on Glioblastoma Patients: A Systematic Review, Brain Sciences (2023)
10. An Update on Actively Targeted Liposomes in Advanced Drug Delivery to Glioma, International Journal of Pharmaceutics (2021)
11. Effects of Micrornas and Long Non-Coding Rnas on Chemotherapy Response in Glioma, Epigenomics (2022)
12. Current Understanding of the Exosomes and Their Associated Biomolecules in the Glioblastoma Biology, Clinical Treatment, and Diagnosis, Journal of Neuroimmune Pharmacology (2025)
13. Nanoparticles in Cancer Theranostics: Focus on Gliomas, BioNanoScience (2025)
14. Stem Cells and Targeted Gene Therapy in Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)
15. Nanovehicles for Co-Delivery of Anticancer Agents, Drug Discovery Today (2020)
16. Immunoengineering in Glioblastoma Imaging and Therapy, Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology (2019)
17. Exosome Enveloped by Nano Lipid Particle a New Model for Signal Transducer and Activator of Transcription 3 Silencer Ribonucleic Acid Delivery System to a Glioblastoma Mice Model, Cancers (2025)